Effect of chemotherapy sensitivity enhancement by RNA interference targeting p21-activated kinase 1 with 5-fluorouracil on human colon cancer cells
10.3969/j.issn.1006-5725.2015.16.003
- VernacularTitle:p21-活化激酶1靶向siRNA协同5-氟尿嘧啶对大肠癌细胞化疗增敏作用
- Author:
Haitao QING
;
Wei GONG
;
Side LIU
- Publication Type:Journal Article
- Keywords:
Colon cancer;
p21-activated kinase 1;
5-fluorouracil;
Chemotherapy sensitivity
- From:
The Journal of Practical Medicine
2015;31(16):2598-2601
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of p21-activated kinase 1 on chemotherapy sensitivity of 5-fluorouracil. Methods Cell proliferation was measured by CCK8 and apoptosis rate by flow cytometry or Hoechst staining; the expression of Bcl-xl, Bcl-2, XIAP were determined by Western Blot. Results 5-FU combined shRNA-Pak1 group (combination group) could be significantly inhibited in terms of proliferation (P <0.05). The percentage of apoptosis rate in combined group was the highest and the difference among groups indicated statistical significance (P < 0.05). The expression of Bcl-xl, Bcl-2, XIAP in combination group was significantly inhibited compared with 5-FU group or shRNA-Pak1 group. Conclusion PAK1 inhibited by RNA interference can enhance chemotherapy sensitivity of 5-Fu on growth inhibition and apoptosis induction in colon cancer significantly.
